Hematology

Conference Coverage

Repeat VTE risk heightened in HIV patients

SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.

News

FDA approves caplacizumab for aTTP

The injection is approved in combination with plasma exchange and immunosuppressive therapy for adults with acquired thrombotic thrombocytopenia...

Pages